Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 1.1 Form of Dealer Manager Agreement
- 3.11 Form of Certificate of Designation of Preference, Rights and Limitations of Series C Convertible Preferred Stock
- 4.20 Form of Warrant Agreement
- 4.21 Form of Warrant Certificate
- 4.22 Form of Non-transferable Subscription Rights Certificate
- 4.23 Form of Dealer-manager Warrant Certificate
- 5.1 Legal Opinion of Fennemore Craig, P.C.
- 5.2 Legal Opinion of Lowenstein Sandler LLP
- 23.1 Consent of Ernst & Young, LLP
- 99.1 Form of Instructions As to Use of Subscription Rights Certificates
- 99.2 Form of Letter to Stockholders Who Are Record Holders
- 99.3 Form of Letter to Brokers, Dealers, Banks and Other Nominees
- 99.4 Form of Broker Letter to Clients Who Are Beneficial Holders
- 99.5 Form of Beneficial Owner Election Form
- 99.6 Form of Nominee Holder Certification
- 99.7 Form of Notice of Important Tax Information
- Download Excel data file
- View Excel data file
KTRA similar filings
Filing view
External links
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated September 21, 2018 (except Note 11, as to which the date is May 8, 2019), in Amendment No. 2 to the Registration Statement (Form S-1 No. 333-230929) and related Prospectus of DelMar Pharmaceuticals, Inc. for the registration of subscription rights and securities underlying the subscription rights.
Vancouver, Canada, | /s/ Ernst & Young LLP |
May 23, 2019 | Chartered Professional Accountants |